These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Förster resonance energy transfer (FRET) as a tool for dissecting the molecular mechanisms for maturation of the Shigella type III secretion needle tip complex. Dickenson NE; Picking WD Int J Mol Sci; 2012 Nov; 13(11):15137-61. PubMed ID: 23203116 [TBL] [Abstract][Full Text] [Related]
25. Recombinant Expression and Purification of the Shigella Translocator IpaB. Barta ML; Adam PR; Dickenson NE Methods Mol Biol; 2017; 1531():173-181. PubMed ID: 27837491 [TBL] [Abstract][Full Text] [Related]
26. Molecular cloning and biologically active production of IpaD N-terminal region. Hesaraki M; Saadati M; Honari H; Olad G; Heiat M; Malaei F; Ranjbar R Biologicals; 2013 Jul; 41(4):269-74. PubMed ID: 23731655 [TBL] [Abstract][Full Text] [Related]
27. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments. Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747 [TBL] [Abstract][Full Text] [Related]
28. In-silico design and production of a novel antigenic chimeric Shigella IpaB fused to C-terminal of Clostridium perfringens enterotoxin. Arabshahi S; Derakhshandeh A; Nayeri Fasaei B; Novinrooz A Mol Biol Rep; 2019 Dec; 46(6):6105-6115. PubMed ID: 31473892 [TBL] [Abstract][Full Text] [Related]
29. Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates. Mizel SB; Graff AH; Sriranganathan N; Ervin S; Lees CJ; Lively MO; Hantgan RR; Thomas MJ; Wood J; Bell B Clin Vaccine Immunol; 2009 Jan; 16(1):21-8. PubMed ID: 18987167 [TBL] [Abstract][Full Text] [Related]
30. Cloning, expression, and affinity purification of recombinant Shigella flexneri invasion plasmid antigens IpaB and IpaC. Picking WL; Mertz JA; Marquart ME; Picking WD Protein Expr Purif; 1996 Dec; 8(4):401-8. PubMed ID: 8954886 [TBL] [Abstract][Full Text] [Related]
31. IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes. Picking WL; Nishioka H; Hearn PD; Baxter MA; Harrington AT; Blocker A; Picking WD Infect Immun; 2005 Mar; 73(3):1432-40. PubMed ID: 15731041 [TBL] [Abstract][Full Text] [Related]
32. Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Lu T; Das S; Howlader DR; Jain A; Hu G; Dietz ZK; Zheng Q; Ratnakaram SSK; Whittier SK; Varisco DJ; Ernst RK; Picking WD; Picking WL Front Immunol; 2023; 14():1194912. PubMed ID: 37744341 [TBL] [Abstract][Full Text] [Related]
33. Effect of detergent concentration on the thermal stability of a membrane protein: The case study of bacterial reaction center solubilized by N,N-dimethyldodecylamine-N-oxide. Palazzo G; Lopez F; Mallardi A Biochim Biophys Acta; 2010 Jan; 1804(1):137-46. PubMed ID: 19786126 [TBL] [Abstract][Full Text] [Related]
34. Using disruptive insertional mutagenesis to identify the in situ structure-function landscape of the Shigella translocator protein IpaB. Barta ML; Tachiyama S; Muthuramalingam M; Arizmendi O; Villanueva CE; Ramyar KX; Geisbrecht BV; Lovell S; Battaile KP; Picking WL; Picking WD Protein Sci; 2018 Aug; 27(8):1392-1406. PubMed ID: 29672980 [TBL] [Abstract][Full Text] [Related]
35. Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate. Pore D; Chakrabarti MK Vaccine; 2013 Aug; 31(36):3644-50. PubMed ID: 23764536 [TBL] [Abstract][Full Text] [Related]
36. [Enhancement of antibodies to protective domain of surface protective antigen A of Erysipelothrix rhusiopathiae by DNA immunization with plasmids expressing spaA-chimeras]. Chen KX; Li YJ; Zhang FC; Cao WY; Li JW Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Nov; 25(11):984-6. PubMed ID: 19900362 [TBL] [Abstract][Full Text] [Related]
37. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine. Oaks EV; Turbyfill KR Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513 [TBL] [Abstract][Full Text] [Related]
38. Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B. Sung JW; Hsieh SY; Lin CL; Leng CH; Liu SJ; Chou AH; Lai LW; Lin LH; Kwok Y; Yang CY; Chong P Vaccine; 2010 Nov; 28(51):8175-82. PubMed ID: 20937316 [TBL] [Abstract][Full Text] [Related]
39. Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors. Ashida H; Toyotome T; Nagai T; Sasakawa C Mol Microbiol; 2007 Feb; 63(3):680-93. PubMed ID: 17214743 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the vaccine potential of a cytotoxic protease and a protective immunogen from a pathogenic Vibrio harveyi strain. Cheng S; Zhang WW; Zhang M; Sun L Vaccine; 2010 Jan; 28(4):1041-7. PubMed ID: 19897068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]